UK-based drug discovery services provider Peakdale Molecular (part of the Concept Life Sciences Group) has strengthened its sales and marketing team through the addition of a Head of Sales and Marketing.
Gordon Woodrow, BSc in Applied Microbiology, has been appointed Head of Sales and Marketing and joins Peakdale with over 25 years of commercial experience having held a number of senior positions in companies offering scientific services to the pharmaceutical and biotech industries. Prior to joining Peakdale Gordon was responsible for business development and strategic alliances at Proteros Biostructures. Whilst there Gordon played a key role in Proteros’ growth. Before this Gordon was responsible for European Business development at Codexis Inc.
Commenting on his new role Gordon said “Contract services continue to play a greater and more diverse role in drug discovery and development; it is a very exciting time to be in the business. There has been a major shift in thinking with the pharmaceutical and biotech industries now really recognising the benefit of working collaboratively. Peakdale is an innovative and vibrant business which recognises these opportunities and operates in a nimble fashion. It is this creative and forward thinking approach that will further differentiate Peakdale from its competitors and enable it to continue to grow. I am genuinely excited to be part of the talented team at Peakdale.”
Paul Doyle Chief Operating Officer at Peakdale confirmed that the new appointment is part of an ongoing expansion programme for Peakdale: “Consolidation across the pharmaceutical industry means that supplier bases are forever changing and we have to work hard to continue to differentiate ourselves and maintain our positive reputation for offering a broad suite of high quality services. Peakdale anticipates a period of growth and we recognise that in order to carefully manage such growth and to continue to expand we need to have the right mix of people in the business.
“Gordon has a great track record and his balance of industry experience combined with creative thinking will enable us to keep pace with the ever-changing landscape of drug discovery services. This depth of experience is vital to ensuring we genuinely understand what our clients want and need from a partner not just in the sense of what we do, but how we offer it and how we engage.”[/vc_column_text]
About Peakdale Molecular
Peakdale Molecular (part of the Concept Life Sciences Group) is a leading UK-based provider of drug discovery services to the pharmaceutical, biotech, diagnostics and materials sciences. Our integrated drug discovery services include compound design and synthesis, computational chemistry and SAR, ADMET and screening services.
As a company, we have a single aim: to accelerate our customers’ discovery initiatives through innovation.
By applying our renowned skills for problem-solving and open communications, Peakdale scientists pride themselves in seizing the initiative, providing energy, skill and creativity toward the project objectives.
Using its heritage in the supply of rational building blocks for medicinal chemistry, biased screening libraries and custom synthesis as a springboard, Peakdale now operates a comprehensive suite of services for hit-to-lead and lead optimisation studies.
Peakdale operates from two sites in the UK, its headquarters in Chapel-en-le-Frith Derbyshire and at Discovery Park, Kent.